Biotechnology startup

GeneWEAVE

Advancing clinical microbiology with sample-in/susceptibility-out diagnostic solutions

Funding reportedLast round: Series B

Biotechnology

What company datasets say GeneWEAVE raised

Funding, as reported

Reported in all25Min the source's currency
Rounds3
Last roundSeries B
Last round dateJun 2014
Investors listed3

How it ended, so far

Exit

ExitBuyerPriceWhen
AcquiredRoche$425MAug 2015

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put GeneWEAVE in front of investors. Or tell us what we have wrong.